Nominations for the 2010 Lectureship are closed.
The recipient of the Lectureship will be announced in February 2010.
Learn more about the recipient of the 2009 Lectureship. View the list of all prior Lectureship recipients.
The Lectureship
The AACR Princess Takamatsu Memorial Lectureship was established and first presented in 2007 in honor of the late Princess Takamatsu of Japan. During her extraordinary life, Her Imperial Highness Princess Takamatsu expended tremendous efforts toward the public and humanitarian cause of the eradication of cancer. She is regarded as an honored and respected figure in Japan, the United States, and within the international cancer research community as a whole.
Learn more about Princess Takamatsu.
This Lectureship will recognize an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and who embodies the dedication of the Princess to multinational collaborations. The recipient of the Third Annual Lectureship will present a major, 50-minute lecture during the AACR 101st Annual Meeting 2010 in Washington DC, USA (April 17-21, 2010).
The Lecturer will receive an unrestricted cash award of US $10,000, support for the winner and a guest to attend the AACR Annual Meeting, and a commemorative item serving as tangible witness to the singular honor of his/her selection.
Eligibility Criteria
- Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
- The Lectureship will be presented to an individual investigator.
- Institutions or organizations are not eligible for the Lectureship.
Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.
Nomination Process
Nominations must be submitted electronically to awards@aacr.org, no later than 4:00 p.m. United States Eastern Standard Time on Monday, November 16, 2009. Paper nominations will not be accepted. The following materials must be submitted:
Nomination Letter, which must:
- be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;
- the name of the AACR Lectureship for which the candidate is being nominated;
- a brief statement of no more than 50 words summarizing the candidate's achievements for which he or she is being nominated;
- a concise description of the candidate's novel and significant work in cancer research and dedication to multinational collaborations;
- publications supporting these contributions may be directly referenced within the letter (if applicable).
Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.
Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.
Preferred file formats are *.doc. The candidate's CV may be submitted as a .pdf file. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within two business days.
Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.
There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.
Selection
Candidates will be considered by a Selection Committee of international cancer leaders appointed by the President of the AACR. Selection of the Lecturer will be made on the basis of the novel and significant work, its far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and his or her embodiment of the dedication of the Princess to multinational collaborations. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision.
Supporter
Generously supported by the Princess Takamatsu Cancer Research Fund (Japan).
Questions?
Monique P. Eversley, Program Associate
+1 (267) 646-0576; monique.eversley@aacr.org
American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404